Injecting drug users' understanding of hepatitis C

Addictive Behaviors

Volumn 33, Issue 12, 2008, Pages 1602-1605

  O'Brien, Susannah ^a   Day, Carolyn ^b   Black, Emma ^a   Dolan, Kate ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Hepatitis C; Injecting drug use; Knowledge

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; AUSTRALIA; CITY; COMPREHENSION; CROSS-SECTIONAL STUDY; DISEASE MARKER; FEMALE; HEPATITIS C; HUMAN; INFECTION RISK; INTERVIEW; INTRAVENOUS DRUG ABUSE; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; SUBURBAN AREA; SYMPTOM; VIRUS TRANSMISSION;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; NEEDLE SHARING; NEW SOUTH WALES; PATIENT EDUCATION AS TOPIC; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 53049094628     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2008.07.005     Document Type: Article

References (13)

1. Australian Government Department of Health and Ageing and The Australian Institute of Primary Care (2001) National Hepatitis C Resource Manual. La Trobe University, Melbourne, Canberra, Australian Government Department of Health and Ageing and the Australian Institute of Primary Care.
2. Davis M., Rhodes T., and Martin A. Preventing hepatitis C: 'Common sense', 'the bug' and other perspectives from the risk narratives of people who inject drugs. Social Science & Medicine 59 (2004) 1807-1818
3. Hagan H., and Thiede H. Does bleach disinfection of syringes help prevent hepatitis C virus transmission? (Letter). Epidemiology 14 (2003) 628-629
4. Heimer R., Clair S., Grau L.E., Bluthenthal R.N., Marshall P.A., and Singer M. Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction 97 (2002) 1277-1287
5. Hepatitis C Council of New South Wales. Hepatitis C: What you need to know (2001), Hepatitis C Council of New South Wales, Sydney
6. Kaldor J.M., Dore G.J., and Correll P.K.L. Public health challenges in hepatitis C virus infection. Journal of Gastroenterology and Hepatology 15 Suppl (2000) E83-E90
7. Micallef J., Kaldor J.M., and Dore G.J. Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies. Journal of Viral Hepatitis 13 (2006) 34-41
8. National Centre in HIV Epidemiology and Clinical Research (2005) Australian NSP Survey: National Data Report 2000-2004. Sydney, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales.
9. O'Brien S., Day C., Black E., Thetford C., and Dolan K. Injecting drug users' understanding of hepatitis C. NDARC Technical Report No. 262. Sydney, National Drug and Alcohol Research Centre, University of New South Wales (2006)
10. Rhodes T., Davis M., and Judd A. Hepatitis C and its risk management among drug injectors in London: Renewing harm reduction in the context of uncertainty. Addiction 99 (2004) 621-633
11. Shepard C.W., Finelli L., and Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet: Infectious Diseases 5 (2005) 558-567
12. Southgate E., Weatherall A.-M., Day C., and Dolan K. What's in a virus? Folk understandings of hepatitis C infection and infectiousness among injecting drug users in Kings Cross, Sydney. International Journal for Equity in Health 4 (2005)
13. SPSS Inc. SPSS for Windows version 14.0 (2005), SPSS Inc, Chicago